Effects of COVID-19 and medication used for treatment and symptom prevention on the antioxidant status.

Publication date: Feb 03, 2025

It is known that an inflammatory response plays a key role in COVID-19 pathogenesis. An exacerbated inflammatory response can increase oxidative stress in cells. This study aimed to investigate the effects of COVID-19 on parameters of oxidative stress including non-protein thiol antioxidants (NPSH), protein thiols (PSH), total antioxidant capacity (TAC), advanced oxidation protein products (AOPP), myeloperoxidase (MPO), thiobarbituric acid reactive substances (TBARS), ascorbic acid, and reactive oxygen species (ROS) in plasma collected four to six weeks after the diagnosis. This cross-sectional study included a sex-matched sample of 296 adult individuals with 112 positives (cases) and 184 negatives (controls) for COVID-19. Oxidative stress parameters were peripherally analyzed according to previous methods. The results showed a decrease in NPSH (p = 0. 004), TAC (p = 0. 005), ROS (p 

Concepts Keywords
Increase Antioxidants
Myeloperoxidase COVID-19
Pathogenesis Oxidative stress
Thiobarbituric Pandemic
SARS-CoV-2

Original Article

(Visited 4 times, 1 visits today)